公司資料
Titan Pharmaceuticals 股價、新聞與催化劑
- 股票代碼:
- TTNP
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for TTNP.
公司概覽
業務概覽
Titan Pharmaceuticals was a specialty pharmaceutical company focused on implantable and long-acting drug delivery. Its story was built around formulation science and targeted therapies for chronic conditions.
所在地與產業分類
Titan was headquartered in the United States and listed on NASDAQ. It sat in specialty pharma and drug-delivery biotechnology.
商業模式特徵
The business depended on product adoption, regulatory progress, and the ability to monetize a narrow set of delivery technologies. Investors typically watched commercialization and strategic partnerships.
生技產業定位
Titan occupied a niche drug-delivery position within specialty pharma. It is best understood as a small-cap platform story with a strong emphasis on delivery and persistence.
未來催化劑
- Titan Pharmaceuticals is largely a legacy and closeout story, with catalysts limited to any residual asset or strategic update. There is no active standalone growth story left.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。